Abstract
Lymphomatoid papulosis (LyP) is a recurrent, multifocal cutaneous eruption characterized pathologically as an infiltration of large atypical cells surrounded by inflammatory cells (Macaulay, 1968). The large atypical cells resemble Reed Sternberg (RS) cells of Hodgkin disease (HD) (type A LyP cells), or Sézary cells of cutaneous T cell lymphoma (CTCL) (type B LyP cells) (Willemze et al., 1982). In most cases the large atypical cells have an activated helper T cell phenotype (CD30+, CD4+) (Kadin et al., 1985). Approximately 10–20% of LyP cases are associated with a malignant lymphoma, usually CTCL, HD, or a CD30+ large cell anaplastic lymphoma (ALCL), (Weinman and Ackerman, 1981; Willemze et al., 1982; Sanchez et al., 1983; Wantzin et al., 1985; Harrington et al., 1989; Kaudewitz et al., 1990). The skin lesions of LyP can precede, coexist with, or follow the associated lymphoma (Ibid).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cheifitz, S, B Like and J Massague, 1986. Cellular distribution of type I and type II receptors for transforming growth factor-ß. J. Biol. Chem., 261: 9972–9978.
Davis, TH, CC Morton, R. Miller-Cassman, SP Balk and ME Kadin, 1992. Hodgkin’s disease, lymphoblastoid papulosis, and cutaneous T cell lymphoma derived from a common T cell clone. N. Engl. J. Med., 326: 1115–1122.
Ellingsworth, LR, JE Brennan, X Fok, DM Rosen, H Bentz, KA Piez and SM Seyedin, 1986. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor B. J. Biol. Chem., 261: 12362–12367.
Harrington, DS, SW Braddock, KS Blochr, DD Weisenburger, W Sanger and JO Armitage, 1989. Lymphomatoid papulosis and progression to T cell lymphoma: An immunophenotypic and genotypic analysis. J. Am. Acad. Dermatol., 21: 951–957.
Jullien, P, TM Berg and DA Lawrence, 1989. Acidic cellular environments: Activation of latent TGF-beta and sensitization of cellular responses to TGF-ß and EGF. Int. J. Cancer, 43: 886–891.
Kadin, ME, 1985. Common activated helper T cell origin for lymphomatoid papulosis, mycosis fungoides and some types of Hodgkin’s disease. Lancet ii: 864–865.
Kadin, ME, K Nasu, D Sako, J Said and EC Vonderheid, 1985, Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin’s disease associated antigens. Am. J. Pathol., 119: 315–325.
Kadin, ME, MW Cavaille-Coll and CC Morton, 1990. Tumor progression in Ki-1+ cutaneous lymphomas is related to escape from inhibition by transforming growth factor-ß. Blood, 76,Suppl 1, 354a.
Kadin, ME, J Butmarc, A Elovic and D Wong, 1993. Eosinophils are a major source of transforming growth factor-beta (TGF-β) in nodular sclerosing Hodgkin’s disease. Am. J.Pathol., 142: 11–16.
Kaudewitz, P, H Stein, G Plewig et al, 1990. Hodgkin’s disease followed by lymphomatoid papulosis: Immunophenotypical evidence for a close relationship between lymphomatoid papulosis and Hodgkin’s disease. J. Am. Acad. Dermatol., 22: 999–
Kehrl, JH, AB Roberts, LM Wakefield, S Jakeloew, MB Sporn and AS Fauci, 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med., 163: 1037–1050.
Lyons, RM, LE Gentry, AF Purchio and HL Moses, 1990. Mechanism of activation of latent recombinant TGFβl by plasmin. J. Cell Biol., 110: 1361–1367.
Massague, J and B Like, 1985. Cellular receptors for type B transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem., 260: 1626–1645.
McCaffrey, TA, DJ Falcone, CT Brayton, LA Agarwal, FGP Welt and BB Weksler, 1989. Transforming growth factor-ß activity is potentiated by heparin via dissociation of the transforming growth factor-α/ß-2-macroglobulin complex. J. Cell Biol., 109: 441–448.
Macaulay, WL, 1968. Lymphomatoid papulosis: A continuing self healing eruption, clinically benign histologically malignant. Arch. Dermatol., 97: 23–30.
Newcom, SR, ME Kadin and AA Ansari, 1988. Production of transforming growth factor-ß activity by Ki-l positive lymphoma cells and analysis of its role in the regulation of Ki-l positive lymphoma growth. Am. J. Pathol., 131: 569–577.
Sanchez, NP, MR Pittelkow, SA Muller, PM Banks and RK Winkelmann, 1983. The clinicopathologic spectrum of lymphomatoid papulosis: Study of 31 cases. J. Am. Acad. Dermatol., 8: 81–94.
Wantzin, GL, K Thomsen, F Brandup and JK Larsen, 1985. Lymphomatoid papulosis. Development into cutaneous T cell lymphoma. Arch. Dermatol., 121: 792–794.
Weinman, VF and AB Ackerman, 1981. Lymphomatoid papulosis. A critical review and new findings. Am. J. Dermatopathol., 3: 129–163.
Willemze, R, CJ Meyer, WA van Vloten and E Scheffer, 1982. The clinical and histological spectrum of lymphomatoid papulosis. Br. J. Dermatol., 107: 131–144.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kadin, M.E., Davis, T.H., Balk, S.P., Newcom, S.R., Cheifitz, S., Massague, J. (1994). Mechanism for Tumor Progression in Lymphomatoid Papulosis: Hypothesis Based on Studies of Tumor Cell Lines Clonally Derived from Lymphomatoid Papulosis. In: Lambert, W.C., Giannotti, B., van Vloten, W.A. (eds) Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin. NATO ASI Series, vol 265. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1861-7_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1861-7_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5756-8
Online ISBN: 978-1-4615-1861-7
eBook Packages: Springer Book Archive